glp-1 nhs receptor agonists 16-17 GLP-1 - Big appetite

Biomolecules, 15 (1)

All these factors indicate that you possibly just need time or dose adjustment and likely should continue. However, if you have no reduction in appetite after eight to 12 weeks, no weight loss or blood sugar improvement after three to six months or persistent severe side effects that prevent you from going up in dosage, GLP-1s may not be for you, adds Dr

hrs.2025.107770 Chen SD, Chuang YC, Lin TK, Yang JL (2023) Alternative role of glucagon-like Peptide-1 receptor agonists in neurodegenerative diseases

ONeil, P.M

Both drug labels now include ileus, a condition where normal intestinal muscle contractions stop entirely, as a potential adverse event